N/A
N=31
Feasibility of Using sipIT Tools to Increase Compliance With Fluid Consumption Guidelines in Urolithiasis-Prone Subjects
Urolithiasis
Bottom Line
View on ClinicalTrials.gov: NCT03787615 ↗Enrolled (actual)
31
Serious AEs
0.0%
Results posted
Mar 2021
Primary outcome: Primary: Adherence to Intervention Assessed by Study Completion — 27 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- sipIT tools (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Penn State University
- Primary completion
- Dec 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Adherence to Intervention Assessed by Study Completion |
27 | — |
| SECONDARY Difficulty of Use Subscale of the User Burden Scale |
NA | — |
Summary
The purpose of this study is to examine the feasibility of using sipIT tools (i.e., wrist-worn sensors, smart water bottles, mobile applications) to increase compliance with physician-recommended fluid consumption guidelines in participants with a history of urolithiasis. The study aims to: 1) deliver notifications regarding fluid consumption to the FitBit Versa and the participant's smartphone based on the participant's assessed fluid intake, and 2) determine the acceptability of using the sipIT tools to increase fluid consumption. It is hypothesized that receiving notifications regarding fluid consumption will lead to an increased compliance in attaining fluid consumption guidelines. Further, it is hypothesized that the frequency of notifications will diminish across the study duration.
Eligibility Criteria
Inclusion Criteria
- Fluent in spoken and written English, and capable of providing informed consent
- Own an iPhone (version 6 or higher)
- History of urolithiasis
- Willingness to complete all study procedures: completing questionnaires, participating in semi-structured interviews, tracking fluid consumption, wearing a FitBit Versa and receiving notifications on the FitBit and their smartphone for a three-month period
Exclusion Criteria
- Any medical condition that interferes with regular fluid consumption
Data sourced from ClinicalTrials.gov (NCT03787615). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.